Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enterotoxigenic Escherichia Coli Infection”

29 trials

Showing 20 of 29 results

Early research (Phase 1)Study completedNCT02531685
What this trial is testing

Phase 1 Study of dmLT ID Vaccination in Healthy Adults

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)Study completedNCT02556996
What this trial is testing

Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children

Who this might be right for
Diarrhea
U.S. Army Medical Research and Development Command 356
Early research (Phase 1)Study completedNCT00901654
What this trial is testing

ACE527 Safety and Immunogenicity Study

Who this might be right for
Enterotoxigenic E. Coli (ETEC) Infection
TD Vaccines A/S 36
Early research (Phase 1)Study completedNCT02052934
What this trial is testing

Safety of Sublingual dmLT for ETEC

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT00516659
What this trial is testing

ETEC Logistics Trial (TREK)

Who this might be right for
Diarrhea
Intercell USA, Inc. 201
Not applicableUnknownNCT01638039
What this trial is testing

Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections

Who this might be right for
Dysentery
Hillel Yaffe Medical Center 330
Early research (Phase 1)Study completedNCT06896136
What this trial is testing

Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgA

Who this might be right for
Diarrhea Infectious
Mark Klempner 36
Early research (Phase 1)Study completedNCT01147445
What this trial is testing

Phase I Study of ETEC Vaccine

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT00524004
What this trial is testing

Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD

Who this might be right for
Travelers' Diarrhea
Johns Hopkins Bloomberg School of Public Health 36
Testing effectiveness (Phase 2)Study completedNCT01922856
What this trial is testing

Challenge Study of an ETEC Vaccine

Who this might be right for
Enteritis; Escherichia Coli, Enterotoxigenic
U.S. Army Medical Research and Development Command 56
Early research (Phase 1)Study completedNCT00654108
What this trial is testing

Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 62
Early research (Phase 1)Study completedNCT03404674
What this trial is testing

Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)

Who this might be right for
Diarrhea
PATH 50
Early research (Phase 1)Study completedNCT05987488
What this trial is testing

ShigETEC Vaccine Study in Bangladesh

Who this might be right for
Healthy Volunteers
Eveliqure Biotechnologies GmbH 196
Early research (Phase 1)Study completedNCT03922061
What this trial is testing

Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant

Who this might be right for
Polio
University of Vermont 29
Testing effectiveness (Phase 2)Study completedNCT03729219
What this trial is testing

Prevention of Diarrheal Disease Due to Infection With Enterotoxigenic E. Coli (ETEC)

Who this might be right for
Diarrhea
Scandinavian Biopharma AB 749
Testing effectiveness (Phase 2)Study completedNCT03576183
What this trial is testing

Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701

Who this might be right for
Enterotoxigenic Escherichia Coli InfectionDiarrhea
Valneva Austria GmbH 34
Testing effectiveness (Phase 2)Study completedNCT05933525
What this trial is testing

Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.

Who this might be right for
DiarrheaTravelers DiarrheaInfectious Diarrhea
Immuron Ltd. 63
Early research (Phase 1)Study completedNCT00198796
What this trial is testing

Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge Strains

Who this might be right for
Diarrhea
Johns Hopkins Bloomberg School of Public Health 5
Early research (Phase 1)Study completedNCT01644565
What this trial is testing

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

Who this might be right for
Escherichia Coli Infection
U.S. Army Medical Research and Development Command 57
Early research (Phase 1)Ended earlyNCT03548064
What this trial is testing

Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area

Who this might be right for
Gastroenteritis Escherichia ColiImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 75
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation